Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Michail N. Mavros

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2906-2005; OpenAlex author ID A5078756468. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. The association between cardiovascular medication use and survival in patients with advanced pancreatic adenocarcinoma. Co-author DOI 10.1177/17588359261449094↗
  2. Disparities in Extended Venous Thromboembolism Prophylaxis After Pancreatic Cancer Surgery. Last author DOI 10.1245/s10434-025-17465-9↗
  3. Enhancing Neoadjuvant Virotherapy's Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. Co-author DOI 10.3390/biomedicines12071596↗
  4. Clinical Trials of Systemic Chemotherapy for Resectable Pancreatic Cancer: A Review. Co-author DOI 10.1001/jamasurg.2021.0149↗
  5. Symptom Burden of Nonresected Pancreatic Adenocarcinoma: An Analysis of 10,753 Patient-Reported Outcome Assessments. Co-author DOI 10.1097/mpa.0000000000001629↗
  6. Benefits of High-Volume Medical Oncology Care for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis. Co-author DOI 10.6004/jnccn.2019.7361↗
  7. Low rates of specialized cancer consultation and cancer-directed therapy for noncurable pancreatic adenocarcinoma: a population-based analysis. Co-author DOI 10.1503/cmaj.190211↗
  8. Perioperative Blood Transfusion and the Prognosis of Pancreatic Cancer Surgery: Systematic Review and Meta-analysis. Co-author DOI 10.1245/s10434-015-4823-6↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Natalie G. Coburn · 4 shared papers, 2019–2026 · strength 0.67
  2. Kelvin Chan · 1 shared paper, 2026 · strength 0.36
  3. Michael Jonathon Raphael · 1 shared paper, 2026 · strength 0.36
  4. Kelly Dong · 1 shared paper, 2025 · strength 0.33
  5. Julie I. Hallet · 3 shared papers, 2019–2020 · strength 0.32
  6. Timothy Michael Pawlik · 2 shared papers, 2015–2021 · strength 0.21
  7. Bolni Marius Nagalo · 1 shared paper, 2024 · strength 0.17
  8. Khandoker Usran Ferdous · 1 shared paper, 2024 · strength 0.17
  9. Conner Daniel Hartupee · 1 shared paper, 2024 · strength 0.17
  10. Emmanouil Giorgakis · 1 shared paper, 2024 · strength 0.17
  11. Omeed Moaven · 1 shared paper, 2024 · strength 0.17
  12. Matthew H. G. Katz · 1 shared paper, 2021 · strength 0.16
  13. Dimitrios Moris · 1 shared paper, 2021 · strength 0.16
  14. Eileen Mary O'Reilly · 1 shared paper, 2021 · strength 0.16
  15. Paul Jack Karanicolas · 1 shared paper, 2021 · strength 0.16
  16. Ahmed Hammad · 1 shared paper, 2020 · strength 0.11
  17. Stephanie Tung · 1 shared paper, 2020 · strength 0.11
  18. Ying Liu · 1 shared paper, 2019 · strength 0.10
  19. Sten D. Myrehaug · 1 shared paper, 2019 · strength 0.10
  20. Gaya Spolverato · 1 shared paper, 2015 · strength 0.05
  21. Faiz Gani · 1 shared paper, 2015 · strength 0.05
  22. Aslam M. Ejaz · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.